SNMMI publishes AUC for somatostatin receptor PET imaging

Michael Walter | | Radiology Business | Nuclear Medicine

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced Thursday, Jan. 4, the publication of appropriate use criteria (AUC) for somatostatin receptor PET imaging in neuroendocrine tumors.

To develop this AUC, which “addresses several clinical scenarios for neuroendocrine tumors,” SNMMI says it collaborated with several other groups, including the American College of Radiology, the European Association of Nuclear Medicine, the European Neuroendocrine Tumor Society, the American Gastroenterological Association, the American Society of Clinical Oncology and many others.

SNMMI also established a Somatostatin Receptor PET Imaging in Neuroendocrine Tumors Workgroup, putting representatives from several specialties together to “review the scientific literature and develop consensus recommendations.”

More information about the AUC can be found on the SNMMI website. Information specifically about how the AUC was developed is available here.

According to its statement, SNMMI members are also presently developing AUC for the following subjects: gastrointestinal transit, infection imaging, PET myocardial perfusion imaging, prostate cancer imaging, somatostatin imaging, and thyroid imaging and therapy.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Policy reforms in Washington that will impact nuclear imaging
U.S. moves closer to establishing domestic supply of Mo-99 for nuclear imaging
Siemens Healthineers finalizes $223M purchase of Novartis’ imaging unit
GE HealthCare acquires full stake in radiopharma firm that generated $183M last year
Radiologists say hidden fat can predict Alzheimer’s 20 years before symptoms arise
Radiopharmaceutical firm Telix investing up to $171M to acquire portfolio of imaging agents

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.